Alpha 2.0
Login Register
» Authors » Malgorzata Fuksiewicz

Malgorzata Fuksiewicz

Explore the profile of Malgorzata Fuksiewicz including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 27
Citations 219
Followers 0
Related Specialties
Oncology
Gynecology & Obstetrics
General Medicine
Top 10 Co-Authors
Beata Kotowicz
Maria Kowalska
Janina Kaminska
Joanna Jonska-Gmyrek
Mariusz Bidzinski
Magdalena Chechlinska
Jan Walewski
Agnieszka Kolasinska-Cwikla
Agnieszka Jagiello-Gruszfeld
Tadeusz Pienkowski
Published In
Tumour Biol
Clin Chem Lab Med
Eur J Obstet Gynecol Reprod Biol
Cancers (Basel)
Med Oncol
Affiliations
Soon will be listed here.
Recent Articles
1.
Interleukin-6 as a Predictive Factor of Pathological Response to FLOT Regimen Systemic Treatment in Locally Advanced Gastroesophageal Junction or Gastric Cancer Patients
Marcisz-Grzanka K, Kotowicz B, Nowak A, Winiarek M, Fuksiewicz M, Kowalska M, et al.
Cancers (Basel) . 2024 Feb; 16(4). PMID: 38398148
Background: Perioperative treatment is a gold standard in locally advanced gastric cancer or GEJ cancer in the Western population. Unfortunately, the response rate after neoadjuvant chemotherapy (NAC) remains limited. Moreover,...
2.
Prognostic Factors for Uterine Sarcoma and Carcinosarcoma: Insights from a 10-Year Follow-Up Study
Kotowicz B, Danska-Bidzinska A, Fuksiewicz M, Nasierowska-Guttmejer A, Raczkiewicz D, Gujski M, et al.
Med Sci Monit . 2023 Dec; 29:e941562. PMID: 38058118
BACKGROUND Uterine sarcomas and carcinomas are rare tumors and treatment outcomes are far from expected. We investigated the prognostic significance of selected serum biomarkers and the impact of some clinical...
3.
Expression of Soluble Form of Aurora A as a Predictive Factor for Neoadjuvant Therapy in Breast Cancer Patients: A Single-Center Pilot Study
Winter P, Fuksiewicz M, Jagiello-Gruszfeld A, Nowecki Z, Kotowicz B
Cancers (Basel) . 2023 Nov; 15(22). PMID: 38001709
Purpose: To search for new predictive breast cancer biomarkers. We analyzed the serum concentrations of biomarkers involved in carcinogenesis, which can also be targeted by therapy. Methods: In a single-center...
4.
Prognostic value of coronary atherosclerosis and CAC score for the risk of chemotherapy-related cardiac dysfunction (CTRCD): The protocol of ANTEC study
Borowiec A, Ozdowska P, Rosinska M, Jagiello-Gruszfeld A, Jasek S, Waniewska J, et al.
PLoS One . 2023 Aug; 18(8):e0288146. PMID: 37590267
Background: Cardiological complications of oncological treatment, including the most serious one, heart failure, constitute a significant and still unsolved clinical problem. A history of dyslipidemia and complications of atherosclerosis, including...
5.
Measurement of HE4 six months after first-line treatment as optimal time in identifying patients at high risk of progression advanced ovarian cancer
Kotowicz B, Fuksiewicz M, Bidzinski M, Berezowska A, Sobiczewski P, Kowalska M
Ginekol Pol . 2023 Jan; 93(11):910-915. PMID: 36621970
Objectives: The objective of the study was to assess the usefulness of determining HE4 and CA125 in ovarian cancer patients, to indicate which of the measurements may be optimal in...
6.
Serum levels of neuron-specific enolase as a prognostic factor for disease progression in patients with GET/NEN in the pancreas and the small intestine
Fuksiewicz M, Kowalska M, Kolasinska-Cwikla A, Kotowicz B
Endocr Connect . 2022 Jul; 11(9). PMID: 35900770
The aim of this study was to assess the usefulness of neuron-specific enolase (NSE) concentrations as a prognostic factor in patients with neuroendocrine neoplasms and to determine the relationship between...
7.
The Impact of Dietary Counselling on Achieving or Maintaining Normal Nutritional Status in Patients with Early and Locally Advanced Breast Cancer Undergoing Perioperative Chemotherapy
Jodkiewicz M, Jagiello-Gruszfeld A, Surwillo-Snarska A, Kotowicz B, Fuksiewicz M, Kowalska M
Nutrients . 2022 Jun; 14(12). PMID: 35745270
Obesity is an independent prognostic factor and is associated with poorer response to oncological treatment of breast cancer. Obesity is associated with shorter overall survival and shorter time to recurrence....
8.
CXCR4/ACKR3/CXCL12 axis in the lymphatic metastasis of vulvar squamous cell carcinoma
Rusetska N, Kowalski K, Zalewski K, Zieba S, Bidzinski M, Goryca K, et al.
J Clin Pathol . 2021 Mar; 75(5):324-332. PMID: 33692092
Aims: Vulvar squamous cell carcinoma (VSCC) spreads early and mainly locally direct expansion into adjacent structures, followed by lymphatic metastasis to the regional lymph nodes (LNs). In the lymphatic metastasis,...
9.
Pretreatment neutrophil to lymphocyte and platelet to lymphocyte ratios as predictive factors for the survival of cervical adenocarcinoma patients
Jonska-Gmyrek J, Gmyrek L, Zolciak-Siwinska A, Kowalska M, Fuksiewicz M, Kotowicz B
Cancer Manag Res . 2018 Dec; 10:6029-6038. PMID: 30538552
Objective: Our study assessed the clinical utility and prognostic value of pretreatment hematological parameters and calculated coefficients including the platelet to lymphocyte ratio (PLR), neutrophil to lymphocyte ratio (NLR), and...
10.
Prognostic value of chromogranin A in patients with GET/NEN in the pancreas and the small intestine
Fuksiewicz M, Kowalska M, Kolasinska-Cwikla A, Cwikla J, Sawicki L, Roszkowska-Purska K, et al.
Endocr Connect . 2018 May; 7(6):803-810. PMID: 29724794
The aim of this study was to evaluate the clinical usefulness of the chromogranin A (CgA) determination in patients with neuroendocrine neoplasms (NENs) of the digestive system and to analyse...